Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cunte Chen, Chi Leong Chio, Hui Zeng & Yangqiu Li. (2021) High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia. Hematology 26:1, pages 210-214.
Read now
Read now
Articles from other publishers (6)
Ruiqi Wang, Yuanyuan Xu, Bianhong Wang, Hong Wang, Mengzhen Wang, Yu Jing, Xiaoning Gao & Li Yu. (2023) Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study. Annals of Hematology.
Crossref
Crossref
Minhui Zeng, Keke Chen, Xin Tian, Runying Zou, Xiaoqin Feng, Chunfu Li, Jian Li, Mincui Zheng, Huirong Mai, Lihua Yang, Yingyi He, Honggui Xu, Hong Wen & Xiangling He. (2023)
Clinical characteristics and prognosis analysis of patients with de novo
ASXL1
‐mutated
AML
treated with the
C‐HUNAN‐AML
‐15 protocol: A multicenter study by the South China Pediatric
AML
Collaborative Group
. Cancer Medicine 12:12, pages 13182-13192.
Crossref
Crossref
Ao Zhang, Shuxing Wang, Quanlei Ren, Yizhu Wang & Zhiping Jiang. (2022)
Prognostic value of
ASXL1
mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis
. Asia-Pacific Journal of Clinical Oncology.
Crossref
Crossref
Karilyn T. Larkin, Deedra Nicolet, Benjamin J. Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E. Miller, Saranga Wijeratne, Gregory Wheeler, Jessica Kohlschmidt, James S. Blachly, Alice S. Mims, Christopher J. Walker, Christopher C. Oakes, Shelley Orwick, Isaiah Boateng, Jill Buss, Adrienne Heyrosa, Helee Desai, Andrew J. Carroll, William Blum, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Robert J. Mayer, Richard A. Larson, Richard M. Stone, Electra D. Paskett, John C. Byrd, Elaine R. Mardis & Ann-Kathrin Eisfeld. (2022) High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. Blood Advances 6:19, pages 5570-5581.
Crossref
Crossref
P.V. Lipilkin, E.D. Kulaeva & E.V. Mashkina. (2022) Prognostic value of ASXL1 mutations in acute myeloid leukemia: A meta-analysis. Leukemia Research 120, pages 106910.
Crossref
Crossref
Sorina Mihaela Papuc, Alina Erbescu, Diana Cisleanu, Diana Ozunu, Cristina Enache, Ion Dumitru, Elena Lupoaia Andrus, Mihaela Gaman, Viola Maria Popov, Maria Dobre, Oana Stanca, Silvana Angelescu, Nicoleta Berbec, Andrei Colita, Ana-Maria Vladareanu, Horia Bumbea & Aurora Arghir. (2021) Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies. Genes 12:6, pages 846.
Crossref
Crossref